Sean Laaman

Stock Analyst at Morgan Stanley

(3.61)
# 241
Out of 5,243 analysts
2
Total ratings
100.00%
Success rate
69.94%
Average return
Main Sectors:
2 Stocks
Name Action Price Target Current % Upside Ratings Updated
BeiGene
Assumes: Overweight
300
n/a n/a 1 Dec 3, 2024
ResMed
Upgrades: Overweight
169
232.62 -27.35% 1 Oct 27, 2023